Walden Biosciences
Cambridge
About Walden Biosciences
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease. Founded by world-renowned experts in renal disease, Walden is applying its unique, systems-based approach to address the intersection between the pathology and biology of kidney disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $51.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2023)
- Website: waldenbiosciences.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/walden-biosciences-56721 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.